Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595478 · ClinicalTrials.gov registry record · NA
Family Based Contingency Management for Adolescent Alcohol Abuse
A NA study, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 75
- Enrollment target
NCT00595478 is a NA study that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 75 participants.
The verdict
NCT00595478, a NA study, has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 75 participants
- Enrollment target
Study Summary
The goal is to adapt the family-based CM treatment to target primary adolescent alcohol abuse and dependence. Specific Aim 1 is to provide a preliminary demonstration of the efficacy of a family-based CM intervention to treat adolescent alcohol abuse and dependence. CM components include: 1. an incentive program to enhance the adolescent's engagement in the treatment process and engender alcohol abstinence by providing positive reinforcement for documented abstinence via breathalyzers administered by parents regularly at home, self and parent report, and clinic-based urine drug testing; and 2. a parent management training program to enhance and maintain the positive effects of the incentive program by teaching parents how to effectively use contingency management in the home environment to motivate their adolescent to achieve abstinence and improve their behavior in other domains. A randomized trial will determine whether the CM intervention enhances outcomes when added to a standard individual cognitive behavioral therapy (CBT). Specific Aim 2 is to determine whether and how treatment interventions modify parental and adolescent risk and protective factors using observational and laboratory measures (parenting practices, family functioning, risk taking, delay discounting, and child and parent psychopathology) and to determine whether these factors are associated with outcomes over time. Specific Aim 3 is to test gene x environment (treatment) interactions in adolescent substance abuse. Findings will extend the scientific evidence for CM and support the ability of parents to implement CM at home. Findings that support the CM model's efficacy will make a significant contribution to research on the treatment of adolescent alcohol abuse, which has lagged behind research on adult substance abuse and on adolescent illicit drug use.
Interventions
- BEHAVIORAL Motivational Enhancement Therapy (MET)/CBT+CM
- BEHAVIORAL Motivational Enhancement Therapy (MET)/CBT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2007-08 |
| Est. Completion | 2014-05 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00595478
The ClinicalTrials.gov registry entry for NCT00595478 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 75 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Motivational Enhancement Therapy (MET)/CBT+CM is the first listed.
NCT00595478 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00595478 about?
NCT00595478 is a clinical study titled "Family Based Contingency Management for Adolescent Alcohol Abuse". The goal is to adapt the family-based CM treatment to target primary adolescent alcohol abuse and dependence. Specific Aim 1 is to provide a preliminary demonstration of the efficacy of a family-based CM intervention to treat adolescent alcohol abuse and dependence. CM components include: 1. an in...
What is the current status of trial NCT00595478?
This trial is currently completed. It is a NA study. The enrollment target is 75 participants. The study started on 2007-08. Estimated completion is 2014-05.
What interventions are being tested in trial NCT00595478?
The interventions under investigation include: Motivational Enhancement Therapy (MET)/CBT+CM (BEHAVIORAL), Motivational Enhancement Therapy (MET)/CBT (BEHAVIORAL).
Who is sponsoring clinical trial NCT00595478?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.